title: Long-term therapy with bevacizumab in hereditary hemorrhagic telangiectasia.
authors.forename: Brian T
authors.initials: BT
authors.lastname: Brinkerhoff
authors.forename: David M
authors.initials: DM
authors.lastname: Poetker
authors.forename: Nicholas W
authors.initials: NW
authors.lastname: Choong
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D004844:Epistaxis / Q000188:drug therapy; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D013683:Telangiectasia, Hereditary Hemorrhagic / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D006454:Hemoglobins; D000068258:Bevacizumab